Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 20226630)

1.

Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.

Venkatasubramanian G, Chittiprol S, Neelakantachar N, Shetty T, Gangadhar BN.

Schizophr Res. 2010 Jun;119(1-3):131-7. doi: 10.1016/j.schres.2010.01.033. Epub 2010 Mar 11.

PMID:
20226630
2.

Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.

Denko CW, Malemud CJ.

Semin Arthritis Rheum. 2005 Aug;35(1):24-34. Review.

PMID:
16084221
3.

A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.

Bradley AJ, Dinan TG.

J Psychopharmacol. 2010 Nov;24(4 Suppl):91-118. doi: 10.1177/1359786810385491. Review.

PMID:
20923924
4.

Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis.

Maia-de-Oliveira JP, Trzesniak C, Oliveira IR, Kempton MJ, Rezende TM, Iego S, Baker GB, Dursun SM, Machado-de-Sousa JP, Hallak JE.

Rev Bras Psiquiatr. 2012 Oct;34 Suppl 2:S149-55. Review. English, Portuguese.

5.

Converging evidence of blood-based biomarkers for schizophrenia: an update.

Chan MK, Guest PC, Levin Y, Umrania Y, Schwarz E, Bahn S, Rahmoune H.

Int Rev Neurobiol. 2011;101:95-144. doi: 10.1016/B978-0-12-387718-5.00005-5. Review.

PMID:
22050850
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk